RELMα and RELMβ can regulate different physiological and pathological processes, including lung and intestinal inflammation, lung cell proliferation, glucose metabolism, skin and colon barrier defense, etc., and are related to the progression of multiple diseases such as lung diseases, intestinal diseases, cardiovascular diseases, and cancers. The gene discussed is RETNLB; the disease is cardiovascular disorder.